Article
A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G>A mutation, ISMMSi002-B, for disease modeling.
Stem cell research - 1 Aug 2017
Klein Sandra, Dvornik Jill L, Yarrabothula Akshitha R, Schaniel Christoph
Abstract excerpt
Fibroblasts of a 28-year-old female with Marfan syndrome (MFS) due to a heterozygous FBN1 c.4082G>A mutation were reprogrammed using the Sendai virus delivery method. The established human induced pluripotent stem cell (hiPSC) line named ISMMSi002-B expresses pluripotency markers, has a normal karyotype, carries the specific FBN1 mutation and is able to differentiate into three germ layers in vitro. ISMMSi002-B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
